Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
about
PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophagesStrain-dependent activation of NF-kappaB in the airway epithelium and its role in allergic airway inflammationAnti-inflammatory activity of a novel family of aryl ureas compounds in an endotoxin-induced airway epithelial cell injury modelInhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumoniaRegulation of COX-2 expression and IL-6 release by particulate matter in airway epithelial cellsGlutaredoxin 1 regulates cigarette smoke-mediated lung inflammation through differential modulation of I{kappa}B kinases in mice: impact on histone acetylation.A review of the application of inflammatory biomarkers in epidemiologic cancer research.SmgGDS regulates cell proliferation, migration, and NF-kappaB transcriptional activity in non-small cell lung carcinoma.Gene-specific repression of proinflammatory cytokines in stimulated human macrophages by nuclear IκBα.Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases.Aerosol-mediated delivery of AAV2/6-IκBα attenuates lipopolysaccharide-induced acute lung injury in rats.Gut flora enhance bacterial clearance in lung through toll-like receptors 4NFkappaB is persistently activated in continuously stimulated human neutrophils.Small interfering RNA targeting NF-κB attenuates lipopolysaccharide-induced acute lung injury in rats.Hypercapnic acidosis attenuates pulmonary epithelial stretch-induced injury via inhibition of the canonical NF-κB pathwayC1P Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Preventing NF-κB Activation in Neutrophils.Downregulation of COMMD1 by miR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells.Protein kinase C and acute respiratory distress syndrome.Budesonide inhalation ameliorates endotoxin-induced lung injury in rabbits.Pulmonary effects of inhaled limonene ozone reaction products in elderly rats.Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration.Recent patents on therapeutic applications of the transcription factor decoy approach.A decoy oligonucleotide to NF-κB delivered through inhalable particles prevents LPS-induced rat airway inflammation.Anacardic acid, a histone acetyltransferase inhibitor, modulates LPS-induced IL-8 expression in a human alveolar epithelial cell line A549.Hepatitis B virus X protein induces IKKα nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells.Adenovirus-delivered angiopoietin-1 suppresses NF-κB and p38 MAPK and attenuates inflammatory responses in phosgene-induced acute lung injury.Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation.15-deoxy-delta 12,14-prostaglandin J2 prevents inflammatory response and endothelial cell damage in rats with acute obstructive cholangitis.Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.Role of NF-κB activation and Th1/Th2 imbalance in pulmonary toxicity induced by nano NiO.Biomechanical aspects of the auto-digestion theory.
P2860
Q23911525-D28BD005-1969-494E-B1B6-52C943870447Q28393042-AEA7897E-7EC3-463F-B439-1A2E91D953F2Q28485098-8967CBCC-CEC5-4E04-8AE5-A431F795784BQ33750381-701EA786-6211-4BA9-8A05-042BC2FB6866Q33765074-B34ACE5C-98BA-4180-8341-69CAF883E2EFQ34085544-CFC77CFB-F7E9-4229-A0D4-616339710C89Q34135803-82258AE6-8871-4318-919E-075EBABB707AQ34704519-3D4EE9C2-1C32-45BF-87C4-79F292EA449AQ34807206-861C319A-D0EE-4107-9B72-1A4D84A0FA0BQ34979016-20706F84-D726-4D4F-B8DA-D78D352C832DQ34999489-632B5449-3FCB-4A1F-B50D-F3AD076133CAQ35231183-6095B672-4BB6-488F-BE24-7535DB46CD40Q35844096-9758D75B-9F23-4D57-A7BC-9DC9B39E8246Q36235048-B7B13BAB-AF01-4718-85F4-493BE81EFF1BQ36712297-2DB9407C-6580-4AE5-8C7B-5F825E9C79E7Q36764068-48A98173-5615-4C16-9287-7961F79D6C6CQ36799298-D60C7056-338B-4AFE-9E61-9A02FAD8AB07Q37016386-D512DE0B-5F9B-4154-8D45-B6447676CE94Q37071326-20938226-F4CE-456C-AE2C-EDC0E565A6DAQ37409620-AB6A43DC-D805-4B9E-96D8-A76BAE5488BFQ37552431-03D3559A-AAF5-41F4-AAA2-933311984F95Q37948111-403DE799-CE43-46FA-9299-BBEC613B143CQ38316293-3FAC1782-E143-4B73-9BD5-13973DEC4192Q39219749-B0BA4F39-E97D-4A84-8834-B00C47BF95BAQ39535085-297B01A7-3200-448B-8FF8-1D3DA2CC470CQ42237706-546BF1A8-A12F-4A39-A9A0-DC51CB8F3303Q43119866-815C5E36-B5F2-414F-A5F2-F3E85C6468ACQ43199847-3049D0B6-B52F-438B-9E6C-FB39BC9FE2B8Q50213668-8993727D-EAE9-4EDF-9B2A-C0FCF95D2763Q51612409-F3D2D640-9D00-454B-8F29-EA8E76067B0FQ55070889-9B807BA9-E3B7-4C9A-9F57-1CF0B2164902
P2860
Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
@ast
Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
@en
type
label
Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
@ast
Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
@en
prefLabel
Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
@ast
Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
@en
P1433
P1476
Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
@en
P2093
Gye Young Park
John W Christman
P304
P356
10.2174/138945006777435317
P577
2006-06-01T00:00:00Z